GlobalData expects AI use in medical devices industry to grow at CAGR of 29.1% to US$1.2B in 2027, driven by demand for health care system to reduce time, costs and missed detections when diagnosing growing number of patients with complex profiles

Sample article from our Transformation & Innovation

November 6, 2023 (press release) –

The global market for artificial intelligence in the medical devices industry is set to grow at a compound annual growth rate (CAGR) of 29.1% from $336 million in 2023 to $1.2 billion in 2027, driven by the demand for healthcare systems to reduce time, costs, and missed detections when diagnosing a growing number of patients with complex profiles, forecasts GlobalData, a leading data and analytics company.

Brian Hicks, Senior Analyst of Medical Devices at GlobalData, comments: “A common use of AI in medical has been in diagnostic settings, where the speed and accuracy of diagnosing difficult-to-identify image abnormalities by the human eye are flagged by AI algorithms. The consequence of this is that more patient profiles can be reviewed while also minimizing any potential misdiagnoses.”

GlobalData’s “Artificial Intelligence (AI) in Healthcare – Thematic Research” report reveals that the underlying technology that drives this trend is referred to as computer vision, and its diagnostic applications are leveraged by wide-ranging specialists.

The use of AI in decreasing error rates of cancer detection has already well demonstrated, where one study as far back as 2016 by Wang and colleagues showed that pathologists who had utilized AI in detecting cancer-positive lymph nodes had reduced their error rate from 3.4% to 0.5%.

Hicks adds: “Furthermore, due to the ability of AI to flag potential indication-positive cases in a fraction of the time it takes for physicians, with similar if not greater accuracy, many additional patient profiles can be reviewed with unprecedented speed.”

Various companies, including startups like Aidoc are specializing in medical imaging using AI and its associated deep learning technology. GlobalData research reveals that most of the AI-related investments in the medical industry are poured into those within the imaging and diagnostic spaces, as more traditional hardware and surgical instrument-focused MedTech companies have relatively limited opportunities to incorporate such technologies into their products.

Hicks concludes: “The importance of early detection of any indication cannot be understated; thus, the ability for AI to improve and analyze difficult-to-detect tissue abnormalities, symptoms, and complex patient profiles will enable earlier interventions and patient outcome.”

Media Enquiries

If you are a member of the press or media and require any further information, please get in touch, as we're very happy to help.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order transformation & innovation coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.